Ablynx attracts interest from Boehringer Ingelheim, Abbvie, Merck&Co, Merck KGaA, Sanofi, Galapagos
Boehringer Ingelheim, Abbvie, Merck&Co, Merck KGaA, Sanofi and Galapagos might also be interested in Ablynx, reported Belgian daily De Tijd based on unnamed sources.
Biotech company Ablynx rejected the take over bid by Novo Nordisk, but according to the report, it is possible Novo will put in a higher offer. The companies listed in the article already cooperate with Ablynx. They know the people and technology and might want to prevent the knowledge from coming into a competitor's hands, the report said.
Link to original source (De Tijd)